KA/EN
Register
Medicines reference
Search
Search
Product

Levetam

Favourites

Levetiracetam · Polifarma Ilac, World Medicine

4 forms: coated tablet, solution. In force in Georgia: 1 of 4 (human register).

Forms and doses1 of 4 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Used for: Epilepsy, Status epilepticus or cluster seizures

Choose species and weight; the matching row will be highlighted.
Form Species Dose Frequency Georgia
100 mg/ml, Solution · Cat Cat No dose for this species
No cat IV dose: the only feline IV data are a single-dose pharmacokinetic study in healthy cats; no consensus, label or clinical study gives a cat IV regimen.
 - Georgia Yes, human
In force until 09 Dec 2027
Human (Ministry of Health, RAMA)
In the register: ლევეტამი 500მგ/5მლ კონცენტრატი საინფუზიო ხსნარის მოსამზადებლად 5მლ ფლაკონი #1
№ რ-036393
Verified on: 29 Oct 2026
100 mg/ml, Solution · Dog Dog 30–60 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (Hardy 2012), same substance and route. Status epilepticus or repetitive seizures: 30-60 mg/kg IV once. Dilute (this concentrate is 100 mg/ml) and give slowly; a rapid undiluted 60 mg/kg bolus caused tachycardia, hypotension and hyperglycaemia.
 · once, after diazepam		 once, after diazepam Georgia Yes, human
In force until 09 Dec 2027
Human (Ministry of Health, RAMA)
In the register: ლევეტამი 500მგ/5მლ კონცენტრატი საინფუზიო ხსნარის მოსამზადებლად 5მლ ფლაკონი #1
№ რ-036393
Verified on: 29 Oct 2026
Details: pack, label wording, sources, registration

Levetam 100 mg/ml, Solution

concentrate for solution for infusion, human medicine
Composition / strength
Levetiracetam100 mg/ml
Formulation Type
Solution
Administration route
Intravenous
Manufacturer
Polifarma Ilac · Türkiye
Registration
Georgia Yes, human
In force until 09 Dec 2027
Human (Ministry of Health, RAMA)
In the register: ლევეტამი 500მგ/5მლ კონცენტრატი საინფუზიო ხსნარის მოსამზადებლად 5მლ ფლაკონი #1
№ რ-036393
Verified on: 29 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
No dose for this species
No cat IV dose: the only feline IV data are a single-dose pharmacokinetic study in healthy cats; no consensus, label or clinical study gives a cat IV regimen.
 Cat Any weight Intravenous -
JAVMA 2008 (12 cats)
Scientific article
A study or review published in a scientific journal. Its findings apply to the animals and conditions it studied.
Levetiracetam as an adjunct to phenobarbital treatment in cats with suspected idiopathic epilepsy
JAVMA 232:867-872, 2008
30–60 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (Hardy 2012), same substance and route. Status epilepticus or repetitive seizures: 30-60 mg/kg IV once. Dilute (this concentrate is 100 mg/ml) and give slowly; a rapid undiluted 60 mg/kg bolus caused tachycardia, hypotension and hyperglycaemia.
 Dog Any weight Intravenous once, after diazepam
JVIM 2012 (IV, 19 dogs)
Scientific article
A study or review published in a scientific journal. Its findings apply to the animals and conditions it studied.
Double-masked, placebo-controlled study of intravenous levetiracetam for the treatment of status epilepticus and acute repetitive seizures in dogs
Journal of Veterinary Internal Medicine 26:334-340, 2012
From the active substance's dose: the label does not cover this species; off-label for this pack.
250 mg, Coated tablet · Cat Cat 20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (Bailey 2008), same substance and route. Epilepsy: 20 mg/kg every 8 hours (adjunct to phenobarbital in the source study).
 · every 8 hours		 every 8 hours Georgia Expired
Expired on 03 Nov 2021, not renewed yet
Human (Ministry of Health, RAMA)
In the register: ლევეტამი 250მგ შემოგარსული აბი
№ რ-018420; რ-018421
Verified on: 29 Oct 2026
250 mg, Coated tablet · Dog Dog 20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (IVETF 2015), same substance and route. Epilepsy: 20 mg/kg every 8 (to 6) hours; with phenobarbital the dose may need raising, guided by serum levels.
 · every 8 hours		 every 8 hours Georgia Expired
Expired on 03 Nov 2021, not renewed yet
Human (Ministry of Health, RAMA)
In the register: ლევეტამი 250მგ შემოგარსული აბი
№ რ-018420; რ-018421
Verified on: 29 Oct 2026
Details: pack, label wording, sources, registration

Levetam 250 mg, Coated tablet

film-coated tablet, human medicine
Composition / strength
Levetiracetam250 mg
Formulation Type
Coated tablet
Administration route
By mouth
Manufacturer
World Medicine · Türkiye
Registration
Georgia Expired
Expired on 03 Nov 2021, not renewed yet
Human (Ministry of Health, RAMA)
In the register: ლევეტამი 250მგ შემოგარსული აბი
№ რ-018420; რ-018421
Verified on: 29 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (Bailey 2008), same substance and route. Epilepsy: 20 mg/kg every 8 hours (adjunct to phenobarbital in the source study).
 Cat Any weight By mouth every 8 hours
JAVMA 2008 (12 cats)
Scientific article
A study or review published in a scientific journal. Its findings apply to the animals and conditions it studied.
Levetiracetam as an adjunct to phenobarbital treatment in cats with suspected idiopathic epilepsy
JAVMA 232:867-872, 2008
From the active substance's dose: the label does not cover this species; off-label for this pack.
20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (IVETF 2015), same substance and route. Epilepsy: 20 mg/kg every 8 (to 6) hours; with phenobarbital the dose may need raising, guided by serum levels.
 Dog Any weight By mouth every 8 hours
IVETF 2015
Guideline or consensus statement
Recommendations agreed by a panel of veterinary specialists after reviewing the evidence. They guide practice and do not authorise a product.
International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in Europe
BMC Veterinary Research 11:176, 2015
From the active substance's dose: the label does not cover this species; off-label for this pack.
500 mg, Coated tablet · Cat Cat 20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (Bailey 2008), same substance and route. Epilepsy: 20 mg/kg every 8 hours (adjunct to phenobarbital in the source study).
 · every 8 hours		 every 8 hours Georgia Expired
Expired on 03 Nov 2021, not renewed yet
Human (Ministry of Health, RAMA)
In the register: ლევეტამი 500მგ შემოგარსული აბი
№ რ-018422; რ-018423
Verified on: 29 Oct 2026
500 mg, Coated tablet · Dog Dog 20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (IVETF 2015), same substance and route. Epilepsy: 20 mg/kg every 8 (to 6) hours; with phenobarbital the dose may need raising, guided by serum levels.
 · every 8 hours		 every 8 hours Georgia Expired
Expired on 03 Nov 2021, not renewed yet
Human (Ministry of Health, RAMA)
In the register: ლევეტამი 500მგ შემოგარსული აბი
№ რ-018422; რ-018423
Verified on: 29 Oct 2026
Details: pack, label wording, sources, registration

Levetam 500 mg, Coated tablet

film-coated tablet, human medicine
Composition / strength
Levetiracetam500 mg
Formulation Type
Coated tablet
Administration route
By mouth
Manufacturer
World Medicine · Türkiye
Registration
Georgia Expired
Expired on 03 Nov 2021, not renewed yet
Human (Ministry of Health, RAMA)
In the register: ლევეტამი 500მგ შემოგარსული აბი
№ რ-018422; რ-018423
Verified on: 29 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (Bailey 2008), same substance and route. Epilepsy: 20 mg/kg every 8 hours (adjunct to phenobarbital in the source study).
 Cat Any weight By mouth every 8 hours
JAVMA 2008 (12 cats)
Scientific article
A study or review published in a scientific journal. Its findings apply to the animals and conditions it studied.
Levetiracetam as an adjunct to phenobarbital treatment in cats with suspected idiopathic epilepsy
JAVMA 232:867-872, 2008
From the active substance's dose: the label does not cover this species; off-label for this pack.
20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (IVETF 2015), same substance and route. Epilepsy: 20 mg/kg every 8 (to 6) hours; with phenobarbital the dose may need raising, guided by serum levels.
 Dog Any weight By mouth every 8 hours
IVETF 2015
Guideline or consensus statement
Recommendations agreed by a panel of veterinary specialists after reviewing the evidence. They guide practice and do not authorise a product.
International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in Europe
BMC Veterinary Research 11:176, 2015
From the active substance's dose: the label does not cover this species; off-label for this pack.
1000 mg, Coated tablet · Cat Cat 20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (Bailey 2008), same substance and route. Epilepsy: 20 mg/kg every 8 hours (adjunct to phenobarbital in the source study).
 · every 8 hours		 every 8 hours Georgia Expired
Expired on 03 Nov 2021, not renewed yet
Human (Ministry of Health, RAMA)
In the register: ლევეტამი 1000მგ შემოგარსული აბი
№ რ-018424; რ-018425
Verified on: 29 Oct 2026
1000 mg, Coated tablet · Dog Dog 20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (IVETF 2015), same substance and route. Epilepsy: 20 mg/kg every 8 (to 6) hours; with phenobarbital the dose may need raising, guided by serum levels.
 · every 8 hours		 every 8 hours Georgia Expired
Expired on 03 Nov 2021, not renewed yet
Human (Ministry of Health, RAMA)
In the register: ლევეტამი 1000მგ შემოგარსული აბი
№ რ-018424; რ-018425
Verified on: 29 Oct 2026
Details: pack, label wording, sources, registration

Levetam 1000 mg, Coated tablet

film-coated tablet, human medicine
Composition / strength
Levetiracetam1000 mg
Formulation Type
Coated tablet
Administration route
By mouth
Manufacturer
World Medicine · Türkiye
Registration
Georgia Expired
Expired on 03 Nov 2021, not renewed yet
Human (Ministry of Health, RAMA)
In the register: ლევეტამი 1000მგ შემოგარსული აბი
№ რ-018424; რ-018425
Verified on: 29 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (Bailey 2008), same substance and route. Epilepsy: 20 mg/kg every 8 hours (adjunct to phenobarbital in the source study).
 Cat Any weight By mouth every 8 hours
JAVMA 2008 (12 cats)
Scientific article
A study or review published in a scientific journal. Its findings apply to the animals and conditions it studied.
Levetiracetam as an adjunct to phenobarbital treatment in cats with suspected idiopathic epilepsy
JAVMA 232:867-872, 2008
From the active substance's dose: the label does not cover this species; off-label for this pack.
20 mg/kg
Off-label substance bridge: a human levetiracetam product; dose from Core levetiracetam (IVETF 2015), same substance and route. Epilepsy: 20 mg/kg every 8 (to 6) hours; with phenobarbital the dose may need raising, guided by serum levels.
 Dog Any weight By mouth every 8 hours
IVETF 2015
Guideline or consensus statement
Recommendations agreed by a panel of veterinary specialists after reviewing the evidence. They guide practice and do not authorise a product.
International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in Europe
BMC Veterinary Research 11:176, 2015
From the active substance's dose: the label does not cover this species; off-label for this pack.

Known Contraindications

  • Warning
    Phenobarbital speeds levetiracetam clearance (lower peaks, faster elimination); dogs on phenobarbital may need a higher dose, guided by serum levels.
    Sources: ACVIM · JVIM
  • Warning (Dog)
    Intravenous levetiracetam: dilute and give slowly. A rapid undiluted 60 mg/kg bolus caused tachycardia, hypotension, hyperglycaemia and dull mentation in a dog.

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Show all related products (20 more) Hide additional products

Same active ingredients 20

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 29 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗